Non-Enzymatic Geometry-Selective Acylation of Tri- and Tetrasubstituted a,a’-Alkenediols
of the monoacylate was determined by the integration of
1H NMR.
5.9 Hz, 1H), 2.71 (d, J=5.4 Hz, 2H), 1.66 (s, 3H), 1.40–1.09
(m, 18H), 0.90 (t, J=7.2 Hz, 3H); 13C NMR (toluene-d8):
d=169.7, 164.8, 138.8, 134.2, 132.5, 131.5, 130.6, 130.0, 104.2,
62.4, 45.5, 44.2, 31.8, 30.9, 29.6, 29.1, 28.7, 27.8, 26.6, 25.3,
22.7, 13.9; IR (neat): n=3335, 2926, 2855, 1783, 1746,
1542 cmÀ1; MS (FAB): m/z (rel intensity)=591 (M+Na+,
8), 533 (10), 404 (5), 271 (8); HR-MS: m/z=591.1991, calcd.
for C26H36N2O10SNa (M+Na)+: 591.1988.
(E)-2-(Hydroxymethyl)-4-(2-nitrophenylsulfonamido)but-
2-enyl isobutyrate (E-3d): colorless oil. 1H NMR (CDCl3):
d=8.17–8.09 (m, 1H), 7.92–7.84 (m, 1H), 7.81–7.71 (m,
2H), 5.74 (s, 1H), 5.58 (t, J=6.4 Hz, 1H), 4.53 (s, 2H), 4.16
(s, 2H), 3.88 (t, J=6.4 Hz, 2H), 2.39 (s, 1H), 2.06 (s, 3H);
13C NMR (CDCl3): d=171.0, 147.9, 138.2, 133.9, 133.7,
132.9, 131.0, 126.1, 125.4, 65.8, 58.2, 40.5, 20.9; IR (KBr): n=
3525, 3333, 3099, 3023, 2937, 2889, 1731, 1593, 1540, 1366,
1340, 1239 cmÀ1; MS (FAB): m/z (rel intensity)=345 (M+
H+, 10); HR-MS (FAB): m/z=345.0773, calcd. for
C13H17N2O7S (M+H)+: 345.0757. The (E)-stereochemistry
was determined by differential NOE experiments as shown
in the Supporting Information.
(Z)-2-(Hydroxymethyl)-4-(2-nitrophenylsulfonamido)but-
2-enyl isobutyrate (Z-3d): colorless oil. 1H NMR (CDCl3):
d=8.10–8.03 (m, 1H), 7.84–7.77 (m, 1H), 7.73–7.65 (m,
2H), 5.61 (t, J=7.1 Hz, 2H), 4.55 (s, 2H), 3.99 (s, 2H), 3.82
(t, J=6.2 Hz, 2H), 2.05 (s, 1H), 1.99 (s, 3H); 13C NMR
(CDCl3): d=171.2, 147.9, 138.0, 133.8, 133.7, 132.9, 131.0,
125.7, 125.4, 64.4, 59.3, 40.6, 20.8; IR (KBr): n=3526, 3333,
3099, 3023, 2930, 1731, 1593, 1540, 1441, 1365, 1340, 1238,
1165 cmÀ1; MS (FAB): m/z (rel intensity)=345 (M+H+,
10), 327 (5); HR-MS (FAB): m/z=345.0755, calcd. for
C13H17N2O7S (M+H)+: 345.0757. The (Z)-stereochemistry
was determined by differential NOE experiments as shown
in the Supporting Information.
(E)-2-(Hydroxymethyl)-3-methyl-4-(2-nitro-phenylsulfon-
amido)but-2-enyl acetate (E-10a): colorless powder; mp 72–
758C. 1H NMR (CDCl3): d=8.15–8.08 (m, 1H), 7.90–7.84
(m, 1H), 7.79–7.73 (m, 2H), 5.82 (s, 1H), 4.64 (s, 2H), 4.17
(s, 2H), 3.82 (d, J=6.0 Hz, 2H), 2.47 (s, 1H), 2.07 (s, 3H),
1.79 (s, 3H); 13C NMR (CDCl3): d=171.5, 147.9, 135.8,
133.7, 133.7, 133.1, 132.8, 130.9, 125.4, 63.1 60.3, 45.9, 20.9,
17.1; IR (KBr): n=3488, 3220, 2927, 1737, 1543, 1440, 1429,
1381, 1362, 1334, 1295, 1237, 1157, 1031 cmÀ1; MS (FAB):
m/z (rel intensity)=381 (M+Na+, 10), 359 (M+H+, 5);
HRMS (FAB): m/z=359.0912, calcd. for C13H17N2O7S (M+
H)+: 345.0757. The (E)-stereochemistry was determined by
differential NOE experiments as shown in the Supporting
Information.
(E)-2-[(4-Bromo-2-chlorophenoxy)methyl]-3-[(2-nitrophe-
nylsulfonamido)methyl]dec-2-enyl acetate (13): colorless oil.
1H NMR (CDCl3): d=8.12–8.06 (m, 1H), 7.84–7.78 (m,
1H), 7.73–7.67 (m, 2H), 7.47 (d, J=1.8 Hz, 1H), 7.31 (dd,
J=8.7, 1.8 Hz, 1H), 6.79 (d, J=8.7 Hz, 1H), 5.47 (t, J=
6.0 Hz, 1H), 4.71 (s, 2H), 4.58 (s, 2H), 3.84 (d, J=6.4 Hz,
2H), 2.17 (t, J=6.9 Hz, 2H), 2.03 (s, 3H), 1.36–1.24 (m,
10H), 0.88 (t, J=6.9 Hz, 3H); 13C NMR (CDCl3): d=170.8,
153.3, 148.0, 142.2, 133.7, 133.4, 132.8, 132.7, 131.1, 130.6,
129.2, 125.3, 124.5, 115.7, 113.6, 67.0, 62.0, 44.0, 31.7, 31.0,
29.5, 29.1, 28.8, 22.6, 20.9, 14.1; IR (KBr): n=3335, 2927,
2856, 1733, 1717, 1541, 1473, 1362, 1241, 1167, 1125,
1025 cmÀ1; MS (FAB): m/z (rel intensity)=633 (M+H+, 2).
186 (5); HR-MS (FAB): m/z=633.0856, calcd. for
C26H3381Br35ClN2O7S (M+H)+: 633.0860.
(E)-2-{[N-(tert-Butoxycarbonyl)-2-nitrophenylsulfonami-
do]methyl}-3-[(2-nitrophenylsulfonamido]methyl)dec-2-enyl
acetate (14): colorless oil. 1H NMR (CDCl3): d=8.32–8.26
(m, 1H), 8.21–8.16 (m, 1H), 7.93–7.87 (m, 1H), 7.81–7.71
(m, 5H), 6.04 (t, J=6.2 Hz, 1H), 4.67 (s, 2H), 4.51 (s, 2H),
3.85 (d, J=6.0 Hz, 2H), 2.26 (t, J=7.8 Hz, 2H), 2.08 (s,
3H), 1.43–1.26 (m, 19H), 0.89 (t, J=7.2 Hz, 3H); 13C NMR
(CDCl3): d=171.1, 150.0, 148.0, 147.3, 141.3, 134.4, 133.9,
133.7, 133.5, 133.4, 132.8, 131.9, 130.9, 128.0, 125.5, 124.6,
86.1, 77.2, 61.0, 46.7, 43.4, 31.8, 31.0, 29.6, 29.1, 27.8, 22.6,
21.0, 14.1; IR (KBr): n=3336, 3100, 2931, 2858, 1748, 1733,
1716, 1557, 1541, 1472, 1457, 1362, 1223, 1123, 1046 cmÀ1
;
MS (FAB): m/z (rel intensity)=727 (M+H+, 5); HR-MS
(FAB): m/z=727.2300, calcd. for C31H43N4O12S2 (M+H)+:
727.2319.
Procedure for the Competitive Acylation of Table 4
A solution of diol 9d, the competing alcohol 16 or 18 or 19
(1.0 equiv.), catalyst 7 (10 mol% for the total amount of the
alcohols) and 2,4,6-collidine (1.7 equiv. for the total amount
of the alcohols) in CHCl3 (concentration of the substrate:
0.01M) was stirred at room temperature for 15 min. After
being cooled to À608C, acetic anhydride (0.70 equiv. of total
amount of the alcohols=1.4 equiv. for each of the alcohols)
was added and stirred at À608C for 24 h. The reaction was
quenched with MeOH (10 mL), and the solvent was evapo-
rated. The residue was dissolved in AcOEt, washed with 1N
HCl, brine, dried over Na2SO4, filtered and concentrated
under vacuum. The crude compound was purified by prepa-
rative TLC (SiO2, hexane:AcOEt=1:2) to afford the mono-
and diacylates of 9d and the competing alcohol. E/Z ratios
of 10d (monoacylate of 9d) and 17 (monoacylate of 16)
were determined by the integration of the 1H NMR spec-
trum.
Procedure for Mitsunobu Reactions in Scheme 1
To a solution of E-10d (20 mg, 0.05 mmol) in THF were
added the nucleophile (0.50 mmol), DIAD (0.15 mmol) and
PPh3 (0.15 mmol) at room temperature. After being stirred
for 1 h at room temperature, the solvent was evaporated
under vacuum to give a residue. The residue was purified by
preparative TLC on silica gel to give the corresponding Mit-
sunobu products. For the synthesis of 12, 13 and 14, Mel-
drumꢂs acid, 4-bromo-2-chlorophenol and NsNHBoc were
employed as nucleophiles to give 12 (yield: 19 mg, 66%), 13
(yield: 28 mg, 87%) and 14 (yield: 36 mg, quant.), respec-
tively.
(E)-2-[(2,2-Dimethyl-4,6-dioxo-1,3-dioxan-5-yl)methyl]-3-
[(2-nitrophenylsulfonamido)methyl]dec-2-enyl acetate (12):
colorless oil. 1H NMR (toluene-d8): d=7.82 (dd, J=7.8,
1.4 Hz, 1H), 6.91 (dd, J=7.8, 1.4 Hz, 1H), 6.73 (dt, J=7.8,
1.4 Hz, 1H), 6.58 (dt, J=7.8, 1.4 Hz, 1H), 5.99 (t, J=6.2 Hz,
1H), 4.59 (s, 2H), 3.77 (d, J=5.9 Hz, 2H), 3.73 (t, J=
Adv. Synth. Catal. 2012, 354, 3291 – 3298
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3297